Felix Vogt, MD

Original Contribution

Long-Term Clinical Outcome of Sirolimus-Eluting Stent Implantation in Metabolic Syndrome and Diabetes

07/06/2010

Karl-Christian Koch , MD;

Jörg Schröder , MD;

Nikolaus Marx , MD;

Mohammad Almalla , MD;

Rainer Hoffmann , MD;

Verena Deserno , MS;

Felix Vogt , MD;

Ralf Koos , MD;

ABSTRACT: Background. Patients with metabolic syndrome (MetS) are at increased risk of cardiovascular events. The long-term effectiveness of sirolimus-eluting stents (SES) in patients with MetS and in diabetic patients is not well defined....

ABSTRACT: Background....

07/06/2010

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Felix Vogt, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products